Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 10609816)

Published in Lancet on January 11, 2000

Authors

M Vanharanta1, S Voutilainen, T A Lakka, M van der Lee, H Adlercreutz, J T Salonen

Author Affiliations

1: Research Institute of Public Health, University of Kuopio, Finland.

Associated clinical trials:

Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio) | NCT00005260

Articles citing this

ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Intern Med (2016) 1.05

Dietary lignans: physiology and potential for cardiovascular disease risk reduction. Nutr Rev (2010) 1.00

Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food Funct (2014) 0.82

Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous National Health and Nutrition Examination Survey. Eur J Nutr (2015) 0.80

Suitability of a batch in vitro fermentation model using human faecal microbiota for prediction of conversion of flaxseed lignans to enterolactone with reference to an in vivo rat model. Eur J Nutr (2005) 0.80

Plasma enterolactone and breast cancer risk in the Nurses' Health Study II. Breast Cancer Res Treat (2013) 0.79

Flaxseed ingestion alters ratio of enterolactone enantiomers in human serum. J Nutr Metab (2010) 0.76

Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice. Cytotechnology (2016) 0.75

Can rye intake decrease risk of human breast cancer? Food Nutr Res (2010) 0.75

Enterolactone and coronary events. Lancet (2000) 0.75

Association of Polyphenol Biomarkers with Cardiovascular Disease and Mortality Risk: A Systematic Review and Meta-Analysis of Observational Studies. Nutrients (2017) 0.75

Occurrence of "mammalian" lignans in plant and water sources. Planta (2007) 0.75

Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a single-blinded, parallel, dose-comparison study. J Am Coll Nutr (2013) 0.75

Bioconversion of pinoresinol into matairesinol by use of recombinant Escherichia coli. Appl Environ Microbiol (2014) 0.75

Effects of Korean ginseng berry on skin antipigmentation and antiaging via FoxO3a activation. J Ginseng Res (2016) 0.75

Articles by these authors

Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet (1994) 6.02

Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic lifecourse. Soc Sci Med (1997) 5.79

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health (1985) 4.30

Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol (1996) 4.23

Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed) (1983) 4.00

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Theory and action for health promotion illustrations from the North Karelia Project. Am J Public Health (1982) 2.95

Socioeconomic conditions in childhood and ischaemic heart disease during middle age. BMJ (1990) 2.91

Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Br Med J (Clin Res Ed) (1983) 2.80

Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project. Am J Epidemiol (1981) 2.72

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet (2002) 2.65

Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med (1996) 2.49

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature (1994) 2.49

Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J (2002) 2.46

Beer binging and mortality: results from the Kuopio ischaemic heart disease risk factor study, a prospective population based study. BMJ (1997) 2.40

Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland. Circulation (1999) 2.29

Decline in cardiovascular mortality in North Karelia and other parts of Finland. Br Med J (Clin Res Ed) (1986) 2.22

Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in Eastern Finland. Am J Epidemiol (1982) 2.20

Social connections and mortality from all causes and from cardiovascular disease: prospective evidence from eastern Finland. Am J Epidemiol (1988) 2.20

Association between body iron stores and the risk of acute myocardial infarction in men. Circulation (1998) 2.10

Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med (1994) 2.09

Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A (1993) 2.09

Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06

Changes in morbidity and mortality during comprehensive community programme to control cardiovascular diseases during 1972-7 in North Karelia. Br Med J (1979) 2.05

Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol (2003) 1.93

Evaluation of Fecatest, a new guaiac test for occult blood in feces. Clin Chem (1978) 1.91

Effect of training on plasma anabolic and catabolic steroid hormones and their response during physical exercise. Int J Sports Med (1986) 1.91

Hostility and increased risk of mortality and acute myocardial infarction: the mediating role of behavioral risk factors. Am J Epidemiol (1997) 1.89

Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med (1970) 1.88

Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst (1994) 1.85

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia (2004) 1.85

Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Am J Epidemiol (1985) 1.84

Immunological detection of faecal occult blood in colorectal cancer. Br J Cancer (1984) 1.84

Childhood socioeconomic position and cognitive function in adulthood. Int J Epidemiol (2001) 1.84

Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care (1997) 1.80

Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med (1982) 1.77

Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation (2000) 1.76

Stopping smoking and long-term mortality after acute myocardial infarction. Br Heart J (1980) 1.74

Ten years of the North Karelia Project: results with community-based prevention of coronary heart disease. Scand J Soc Med (1983) 1.71

Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol (2001) 1.70

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation (1995) 1.67

Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet (1982) 1.66

Socioeconomic status and risk of cancer, cerebral stroke, and death due to coronary heart disease and any disease: a longitudinal study in eastern Finland. J Epidemiol Community Health (1982) 1.64

Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ (1997) 1.61

Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med (1991) 1.60

Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res (1997) 1.58

Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer (2000) 1.56

Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4). J Nutr (2001) 1.55

A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect (1998) 1.55

Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol (2000) 1.54

Anger expression and incident stroke: prospective evidence from the Kuopio ischemic heart disease study. Stroke (1999) 1.53

Predictors of disability retirement. Scand J Work Environ Health (1997) 1.52

Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med (2002) 1.52

Does low socioeconomic status potentiate the effects of heightened cardiovascular responses to stress on the progression of carotid atherosclerosis? Am J Public Health (1998) 1.51

When does rheumatoid disease start? Arthritis Rheum (1985) 1.50

Socioeconomic status and progression of carotid atherosclerosis. Prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol (1997) 1.48

Socioeconomic status and carotid atherosclerosis. Circulation (1995) 1.45

Frequent hangovers and cardiovascular mortality in middle-aged men. Epidemiology (1997) 1.45

Workplace conditions, socioeconomic status, and the risk of mortality and acute myocardial infarction: the Kuopio Ischemic Heart Disease Risk Factor Study. Am J Public Health (1997) 1.45

Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc (1994) 1.42

Hopelessness and 4-year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol (1997) 1.42

Systolic blood pressure response to exercise stress test and risk of stroke. Stroke (2001) 1.41

Exaggerated blood pressure responses during mental stress are prospectively related to enhanced carotid atherosclerosis in middle-aged Finnish men. Circulation (2004) 1.41

Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis (2000) 1.41

Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis (1989) 1.40

The "Fecatwin Sensitive" test for fecal occult blood is not intended for use without testing positives with the FECA-EIA assay. Clin Chem (1989) 1.39

Analysis of community-based cardiovascular disease prevention studies--evaluation issues in the North Karelia Project and the Minnesota Heart Health Program. Int J Epidemiol (1986) 1.38

Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis (1990) 1.38

Psychosocial stress and the insulin resistance syndrome. Metabolism (1996) 1.37

Trends in coronary heart disease mortality and morbidity and related factors in Finland. Cardiology (1985) 1.37

The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr (1986) 1.35

Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr (1998) 1.34

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis (1994) 1.32

Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J (Clin Res Ed) (1985) 1.32

Cardiovascular fitness as a predictor of mortality in men. Arch Intern Med (2001) 1.32

Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med (1981) 1.31

The North Karelia youth project: evaluation of two years of intervention on health behavior and CVD risk factors among 13- to 15-year old children. Prev Med (1982) 1.31

Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem (1986) 1.30

Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis (2001) 1.29

Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension (2000) 1.29

Stress-induced blood pressure reactivity and incident stroke in middle-aged men. Stroke (2001) 1.28

Social functioning and overall mortality: prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study. Epidemiology (1994) 1.28

Depression and early retirement: prospective population based study in middle aged men. J Epidemiol Community Health (2005) 1.28

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27

Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr (1995) 1.27